Gevokizumab (S-78989) is a humanised monoclonal antibody targeting IL-1beta, which blocks IL-1beta signalling through allosteric regulation, and can be used for diabetes, cancer, inflammation, and cardiovascular diseases.
Purity:
96.80%
CAS Number:
[1129435-60-4]
Target:
IL Receptor|||Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted